CORE

🇺🇦   make metadata, not war

    1 research outputs found

    P3-069: IFCT0401 trial: Phase II study of gefitinib administered as first-line treatment in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) - Does disease control on gefitinib affect progression free survival and overall survival in ADC-BAC?

    Author
    Publication venue
    International Association for the Study of Lung Cancer. Published by Elsevier Inc.
    Publication date
    Field of study
    Get PDF
    Elsevier - Publisher Connector
    corecore